TWO SIGMA ADVISERS, LP - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 360 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,019,370
-29.3%
253,617
-8.8%
0.02%
-27.6%
Q2 2023$11,345,689
-43.2%
278,217
-48.1%
0.03%
-44.2%
Q1 2023$19,973,627
-1.7%
535,917
-8.0%
0.05%
-8.8%
Q4 2022$20,313,551
-37.8%
582,217
-0.3%
0.06%
-40.0%
Q3 2022$32,676,000
-11.7%
583,917
-18.4%
0.10%
-9.5%
Q2 2022$37,020,000
+16.3%
715,217
+63.3%
0.10%
+23.5%
Q1 2022$31,831,000
-0.6%
438,017
+61.8%
0.08%
+6.2%
Q4 2021$32,010,000
+40.4%
270,717
+59.3%
0.08%
+35.6%
Q3 2021$22,794,000
-65.7%
169,917
-58.6%
0.06%
-66.3%
Q2 2021$66,418,000
+21.8%
410,217
-39.6%
0.18%
+16.7%
Q1 2021$54,551,000
+85.5%
679,717
+25.8%
0.15%
+89.9%
Q4 2020$29,404,000
+223.9%
540,517
+18.4%
0.08%
+203.8%
Q3 2020$9,078,000
+31.1%
456,617
+38.7%
0.03%
+30.0%
Q2 2020$6,922,000
+120.3%
329,317
+28.2%
0.02%
+66.7%
Q1 2020$3,142,000
-7.6%
256,917
+10.8%
0.01%
+50.0%
Q4 2019$3,402,000
+84.1%
231,917
+67.5%
0.01%
+60.0%
Q3 2019$1,848,000
+15.6%
138,417
+41.8%
0.01%
+25.0%
Q2 2019$1,598,000
+163.3%
97,617
+174.8%
0.00%
+100.0%
Q1 2019$607,000
+110.8%
35,517
+68.2%
0.00%
+100.0%
Q4 2018$288,00021,1170.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,216,340$62,958,0007.04%
Discovery Value Fund 584,483$30,253,0006.33%
MPM BioImpact LLC 299,409$15,497,0004.30%
ARK Investment Management 9,514,580$439,003,0002.60%
Elmwood Wealth Management, Inc. 67,899$3,514,0002.00%
Nikko Asset Management Americas, Inc. 2,781,136$141,143,0001.74%
Avidity Partners Management LP 1,125,194$58,240,0001.34%
Merlin Capital, Inc 12,174$630,0001.26%
Atlas Venture Associates IX, LLC 10,000$518,0001.18%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$5,768,0001.16%
View complete list of INTELLIA THERAPEUTICS INC shareholders